chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient stated he experienced bilateral involuntary hand movement, bilateral hand weakness, bilateral leg weakness "shaking"  that started around 9 pm, and lasted until mid morning of 3/6/2021. Patient states, " I was unable to get out of bed for almost 2 days, due to shaking/muscle weakness." Patient states he experienced a fever at the same time. Patient called the nurse number to report a reaction/ seek care, but the patient states. "The person said there was nothing they could do to help him."  Patient had person stay with him to assist him with daily cares.
IMMTRAC 2 HISTORY OF 3 DOSES, OF PFIZER-NO REPORTED RXN.
Redness erythematous 5 1/2 cm x 5 1/2 cm. Warm to touch no swelling, no streaking.
pt recv vax 13MAY96 & pt devel an inj site rxn, characterized by pain, erythema & induration;
Arm hot to touch, muscle stiffness & swelling; No tx to date; Had flu shot 5 yrs ago w/similar rxn; Pt stated she could not raise her arm laterally for over a year;
Upper body shakiness, rapid heart rate Started within a minute of shot.  Rash over face, neck and chest within 10 minutes of shot.  Feeling of nausea  after 25 minutes Selling of tongue with a fuzzy feeling 35 minutes after test.
My arm is swollen. I informed the nurse my first shot was Pfizer. She said it was okay to mix it with Moderna because it's like a booster.
PER PT, REDNESS, SWELLING, HARD TO TOUCH, PAINFUL.
This spontaneous report as received from a public health, healthcare professional refers to unspecified patients of unknown age and gender. On an unknown date the unspecified patients might had vaccinated with improperly stored M-M-R II (lot#, dose, frequency and route unspecified), which were exposed to 53F for 12 hours and M-M-R II (lot#, dose, frequency and route unspecified), which were exposed to 54F for five hours. No adverse effects reported. Follow up information has been received from an office manager concerning a patient. On 08-AUG-2013 the patient was vaccinated with improperly stored M-M-R II (H018181, exp. 05-OCT-2014), which were exposed to 53F for 12 hours (date excursion ended 22-JUL-2013). This is one of several reports received from the same source (linked MARRS#: 1311USA007619, 1311USA011609, 1311USA011611, 1311USA011612, 1311USA011613, 1311USA011614, 1311USA011615, 1311USA011616, 1311USA011617, 1311USA011618, 1311USA011619). Additional information is not expected.
Slight chills, slight headache, temperature 100.6,  intense body aches all over.  Took 2 Advil and 1 extra strength Tylenol at the same time.  Symptoms were gone by noon on 11/20/2021.  Did not seek medical treatment.
Patient. Received her second dose of Pfizer (LOT#: EC3183) at 1835 on 8/17/21. Patient alerted EMT and reported feeling lightheaded, dizzy, was experiencing shortness of breathe and chest pressure. EMT took patients vital signs. BP: 158/78, HR: 49, O2: 100%. Patient stated that the same thing happened with her first dose 40 minutes after completing her observation time. Symptoms resolved with food and rest. Patient also stated that heart rate is low and is normal for her. At 1850 patient stated that she "feels chills" and the chest pressure and dizziness had improved and that she feels sleepy. EMT retook patients vitals signs at 1850. BP: 130/91, HR: 48, O2: 100%. At 1900 patient stated that she had not had any water today and no longer was experiencing any chills or any other symptoms. EMT retook patients vital signs at 1900. BP: 114/72, HR: 43, 02: 100%. EMT retook and reassessed patient at 1911. BP: 104/72, HR: 44, O2: 98%. Patient stated that she was no longer feeling any symptoms. EMT moved patient to zero gravity chair at 1920. Patient completed her observation time. EMT educated patient on adverse effects of COVID vaccine and when to seek EMS. Patient verbalized understanding of education. Patient stood up on her own and walked out of vaccination site with a steady gait at 1924.
dizziness at work; experiencing symptoms the next day including swelling; redness at injection site; pain a little bit (not that much) at injection site; feeling nauseous; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness at work), VACCINATION SITE SWELLING (experiencing symptoms the next day including swelling), VACCINATION SITE ERYTHEMA (redness at injection site), VACCINATION SITE PAIN (pain a little bit (not that much) at injection site) and NAUSEA (feeling nauseous) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced DIZZINESS (dizziness at work), VACCINATION SITE SWELLING (experiencing symptoms the next day including swelling), VACCINATION SITE ERYTHEMA (redness at injection site), VACCINATION SITE PAIN (pain a little bit (not that much) at injection site) and NAUSEA (feeling nauseous). The patient was treated with IBUPROFEN at a dose of 1 dosage form once. On 16-Apr-2021, DIZZINESS (dizziness at work), VACCINATION SITE PAIN (pain a little bit (not that much) at injection site) and NAUSEA (feeling nauseous) had resolved. At the time of the report, VACCINATION SITE SWELLING (experiencing symptoms the next day including swelling) and VACCINATION SITE ERYTHEMA (redness at injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. It was reported that patient took Ibuprofen prior to receiving the vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Outcome of the events Redness at the injection site,Swelling at injection site were changed from Unknown to recovering
24 hours later began feeling body aches, joint pain, headache, then suddenly 26 hrs later experienced extreme chills, pulse 125-160, fever 102.5, then vomiting. Paramedics called and administered zofran. Symptoms dissipated 2 hrs later but still existed. Next 24 hrs temp of 101.5 headache and body ache. 36 hours still fatigued but afebrile
On 05/03/03, pt complained of itching, with erythema, swelling at the site, no respiratory compromise then itch and erythema on contralateral arm. Initially recommend oral antihistamine, local ice, topic HC cream. Pt went to ER that evening, given steroids and Pepcid. Still taking Benadryl for hives - no SOB.
Chest pain, dizziness, shooting pain down arm, up neck. Ringing in ear. Abnormal ekg.
My resting heart rate for years averages 60, but almost immediately after receiving the vaccine, it has steadily increased.  It peaked at 73 and now is coming down.; Also, my right leg is stiff and a bit swollen.; Also, my right leg is stiff and a bit swollen.; This is a spontaneous report from a contactable healthcare professional, the patient. A 67-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 29Apr2021 at 12:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 29Apr2021, the patient experienced that his resting heart rate for years averaged 60, but almost immediately after receiving the vaccine, it had steadily increased and it peaked at 73 and then it was coming down and also, the patient's right leg was stiff and a bit swollen. On 29Apr2021, the patient underwent lab test which included heart rate test and the result was 73 (units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events resting heart rate for years averaged 60, but almost immediately after receiving the vaccine, it had steadily increased and it peaked at 73 and now was coming down and right leg was a bit stiff and swollen was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
headache, chills ( all day of Jan.17) feels icy cold around my ears and face temp. 97, warm/hot temp 98.9, nausea, blurry vision, pass out once 2-3 mins, feverish at night 99.9
COVID-19 TEST POSITIVE; This spontaneous report received from a patient concerned a 56 year adult female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26.cov2.s (dose number in series was 1) (suspension for injection, route of admin was not reported, and batch number: Z07AUA, expiry: unknown) dose was not reported, 1 total, administered in left arm on 03-JUN-2021 for prophylactic vaccination. It was unknown if the patient experienced any adverse event after vaccination covid-19 vaccine ad26.cov2.s. (dose number in series was 1). The patient received covid-19 vaccine ad26.cov2.s (dose number series was 2) (suspension for injection, route of admin not reported, batch number: 1822811, expiry: unknown) dose was not reported, 1 total administered in left arm on 02-DEC-2021 for prophylactic vaccination. No concomitant medications were reported.  On 25-JAN-2022, the patient tested positive for COVID-19 with home antigen test. The patient had not tested with a PCR (polymerase chain reaction) test. (dose number in series was 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sars-cov-2 test positive was not reported. This report was non-serious.
blood pressure drops at different times throughout the day (70/45). working with cardiologist for evaluation and reasoning, has been tapering off HTN medications
very sore vaccine site, body aches, chills/sweats x 2 days starting 24 hours after vaccine fever up to 101 x 1 day started 24 hours after vaccine no appetite x 3 days fatigue x 3 days FYI- I did have COVID in September 2020
Anemia, Plural Effusion, Fluid on Heart - SOB, Fatigue, weight loss late January - March 9th 3 CT scans, 3 thoracentesis
Chills, fever (101.6F), sweating, headache, nauseau, loss of appetite; resolved in 24 hours
Patient reports right shoulder and neck pain that radiates down her right arm. Pt has never had a reaction to vaccination before. Used cold compresses Tylenol without relief. after receiving tetanus vaccine. Went to urgent care and was diagnosed with possible allergic reaction and given Medrol dose pack. There continues to be pain with range of motion over deltoid region. Symptoms are consistent with bursitis.  Xray normal. Soft tissue inflammation found.
Though ped pfizer was 0.1ml, found to be 0.2 ml
Rash all over her body; Diarrhea; A spontaneous report was received from the patient on 08DEC2022 along with additional information received on 12DEC2022. It described a 19-year-old female patient who had "rash all over her body" (PT: Rash) and "diarrhea" (PT: Diarrhoea) following the administration of Vivotif (typhoid vaccine live oral Ty21A) (lot number: unknown) for immunisation. It was reported that the patient had administered Vivotif as scheduled. Reportedly, on an unknown date in DEC2022 (for two days), the patient had a rash all over her body and diarrhea. Furthermore, the patient was prescribed levocetirizine for rash and dicyclomine for diarrhea as treatment medications. Additionally, it was reported that the last dose of Vivotif was administered on 08DEC2022 to the patient. Reportedly the patient stopped taking levocetirizine. On an unknown date in DEC2022, the patient had recovered from "diarrhea" while had not recovered from the event of "rash all over her body" at the time of this report.  No action taken was taken with Vivotif with respect to the reported events.  The patient had a history of drug allergies to Oxybutynin, which presented as rash and did not have a history of other medical conditions and did not other take any other medications.  No additional information was reported.  Company comment: It was reported that a consumer had rash all over her body (rash) and diarrhea (diarrhoea) following the administration of Vivotif. This patient had a history of drug allergy. Considering the case information, the causality of rash and  diarrhoea is assessed as possible with Vivotif (its role cannot be ruled out and confounded by allergy to Oxybutynin). The case is considered non-serious as per medical assessment.; Sender's Comments: It was reported that a consumer had rash all over her body (rash) and diarrhea (diarrhoea) following the administration of Vivotif. This patient had a history of drug allergy. Considering the case information, the causality of rash and  diarrhoea is assessed as possible with Vivotif (its role cannot be ruled out and confounded by allergy to Oxybutynin). The case is considered non-serious as per medical assessment.
sore arm at the injection site; joint ache; low grade fever; bronchial tightness; difficulty breathing; symptoms for 7 days after the vaccine; minor symptoms lasting for about 5 days; This spontaneous report was received from Consumer and refers to a 46-year-old male.  The patient's medical history included severe reaction to prochlorperazine (COMPAZINE). The patient's concurrent conditions were not reported.  Concomitant medications included empagliflozin (JARDIANCE) and metoprolol.   On an unknown date in 2014, the patient received a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injectionunk, administered for prophylaxis (strength, dose details, lot #, and expiry date were not provided). After this vaccination the patient experienced similar symptoms (no details provided) for 7 days after the vaccine.   On an unknown date, the patient received an immunotherapy injection and he experienced minor symptoms lasting for about 5 days.   On 07-FEB-2022 at 10:00, the patient received a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injectionunk, administered intramuscular for prophylaxis (strength, lot #, and expiry date were not provided). After this vaccination the patient experienced similar symptoms (no details provided) for 7 days after the vaccine.   On the same date, he began to experience joint ache and low grade fever that "comes and goes". On an unknown date in Febraury 2022, he also experienced bronchial tightness and difficulty breathing. On 09-FEB-2022, his arm was sore at the injection site. On an unspecified date in February 2022, he went to the doctor who couldn't fit him in, therefore he went to urgent care instead where they gave him an fluticasone propionate (+) salmeterol (ADVAIRE) inhaler. The caller confirmed that these symptoms were not as severe as in 2014.  On 11-FEB-2021, the patient was experiencing more joint pain.   On unknown dates, the patient recovered from general symptoms (2014) and from minor symptoms after immunotherapy injection.  At the time of this report, the patient had not recovered from joint pain, low grade fever, difficulty breathing, bronchial tightness, and soreness at the injection site.   The patient was not sure if these symptoms were due to the vaccine or not. Causality assessment for all the events was reported as unknown.
Patient said she felt pain at injection.  She said she has had pain in the arm and shoulder since injection but pain is going away each day.  She said she can move her arm ok but can"t lift her left arm to put or take off shirt.
Abdominal distress x 5d Re: Rotateq dose # 1, Lot J003951. Do not administer additional doses of Rotavirus vaccine per Dr.
2/5/13 mom noticed slight swelling at injection site. 2/6/13 mom gave TYLENOL to child before he left for school. School nurse examined child and noted that redness & swelling increased. 330 child seen in this office by doctor, BENADRYL given size of softball - swollen & red additional sx - nausea & headache, scratchy throat.
pt given vax & w/in 1/2hr pt became very fussy & cried;lt leg became red & mildly swollen around inj site;APAP was given;ice pack placed on leg x 15-20min;epi given;some clearing of redness;pt calmed down;
My muscle spasms were triggered in my upper body (arms, face and chest)  These were severe spasm's - things like I was unable to hold things in my hand and my voice was cracking in and out
leaking from the syringe that ran down the patient's arm with no reported adverse event; leaking from the syringe that ran down the patient's arm with no reported adverse event; Initial information received on 05-Dec-2022 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves 54 years old female patient and reporter stated leaking from the syringe that ran down the patient's arm with no reported adverse event. (influenza quadrival a-b vaccine) [Fluzone QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 03-Dec-2022, the patient received 0.5 ml dose of suspect influenza quadrival a-b vaccine once with standard strength (lot UT7752KA and expiry date:30-jun-2023) via intramuscular route in the left deltoid for Immunization.  On 03-Dec-2022 there was leaking from the syringe that ran down the patient's arm with no reported adverse event (accidental exposure to product) and (incorrect dose administered) during the administration of influenza quadrival a-b vaccine.  Action taken was not applicable.  Reportedly, Pharmacist stated that she had some difficulty when administering FLUZONE QIV to a patient.  The caller noted leaking from the syringe that ran down the patient's arm. Is this considered a valid dose or does it need to be re-administered? The caller noted that it was a single dose vial and they used the needle and syringe provided with their shipment of the vaccine. The caller stated that it was not the typical syringe that they use. The needle they were provided had an orange safety mechanism. Some of the liquid leaked out between the needle and the vial during administration. The liquid appeared to leak out when the pharmacist pushed on the plunger. Approximately 20% of the vaccine ran down the patient's arm. There was no adverse reaction that the pharmacist was aware of. The patient was not upset but the patient's spouse was very upset. Should they re-administer the dose or will the dose be enough of an immune response? There was no visible damage to the syringe or the vial. This is the only one in the shipment so far that has had difficulty during administration. The caller noted that they had a problem with a different vaccine Fluad. The caller noted that once you tried to inject the Fluad, the plunger wouldn't go down.  At time of reporting, the outcome was Unknown for the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Larger than it was; 2-inch red spot around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (2-inch red spot around the injection site) and VACCINATION SITE ERYTHEMA (Larger than it was) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included METOCLOPRAMIDE, PRAVASTATIN, CITALOPRAM and VITAMINS NOS for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (2-inch red spot around the injection site). On 19-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Larger than it was). At the time of the report, VACCINATION SITE ERYTHEMA (2-inch red spot around the injection site) had not resolved and VACCINATION SITE ERYTHEMA (Larger than it was) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Moderna COVID-19 Vaccine: rash at site of injection (upper arm red and swollen)
Sharp piercing left sided chest pain that radiated to left shoulder and back 7-8/10  on pain scale.  Taking a deep breath made pain worse but no associated shortness of breath.  Pain worsened with attempting to eat food.  Severe symptoms lasted 2-3 hours and then  subsided.  Troponin and other cardiac markers negative.  No history of GI, cardiac, or pulmonary disorders.  Mildly present the first half of the next day (1-2/10) until afternoon then completely resolved
And then "immediately" developed Bell's Palsy; This is a spontaneous report from a contactable consumer (patient). A 64-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: AM9810, Expiration date: Jun2021) via an unspecified route of administration in left arm on 8Mar2021 10:00 (at the of 64-years-old) as first dose single for COVID-19 immunization. No medical history and concomitant medications were reported. Patient had no other vaccinations the same day as her Pfizer COVID-19 vaccine. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date in Mar2021, the patient experienced Bell's palsy symptoms a day or two after getting her first dose of the vaccine. Patient was treated with Prednisone and it did clear up, she didn't have it anymore because she took all of it. Patient did not undergo any lab test. The outcome of Event was recovered on an unspecified date in 2021.